A study presented at the World Stem Cell Summit showed that stem cells derived from a placenta proved effective in improving the condition of patients with Crohn's disease. Celgene Cellular Therapeutics, which is developing the therapy, is working on a Phase II trial of the treatment and is set to start a trial for the treatment in multiple sclerosis patients.

Full Story:
The Detroit News

Related Summaries